1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY
2.1 GLOBAL BIOPHARMACEUTICAL MARKET

3 GLOBAL BIOPHARMACEUTICAL MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL BIOPHARMACEUTICAL MARKET SNAPSHOT

4 GLOBAL BIOPHARMACEUTICAL MARKET OVERVIEW- BY PRODUCT TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY  PRODUCT TYPE
4.1.1.1 TESTOSTERONE GEL
4.1.1.2 BIOTECH VACCINES
4.1.1.3 HUMAN GROWTH HORMONES
4.1.1.4 PURIFIED PROTEINS
4.1.1.5 OTHERS

5 GLOBAL BIOPHARMACEUTICAL MARKET OVERVIEW- BY THERAPEUTIC AREAS
5.1 INTRODUCTION
5.1.1 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY  THERAPEUTIC AREAS
5.1.1.1 ONCOLOGY
5.1.1.2 NEWROLOGY
5.1.1.3 CARDIOVASCULAR
5.1.1.4 DIABETES
5.1.1.5 OTHERS THERAPEUTIC AREA

6 GLOBAL BIOPHARMACEUTICAL MARKET ANALYSIS AND FORECAST, BY END- USER
6.1 INTRODUCTION
6.1.1 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER
6.1.1.1 RESEARCH CENTER
6.1.1.2 PHARMACEUTICAL SECTOR
6.1.1.3 HEALTH CARE INDUSTRY

7 GLOBAL BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
7.1 INTRODUCTION
7.2 KEY TAKEWAYS

8 NORTH AMERICA BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
8.1 MARKET DYNAMICS
8.1.1 DRIVERS
8.1.2 RESTRAINTS
8.1.3 OPPORTUNITIES
8.2 NORTH AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY PRODUCT TYPE
8.3 NORTH AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY THERAPEUTIC AREAS
8.4 NORTH AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY END- USER
8.5 U.S.
8.6 CANADA
8.7 MEXICO

9 EUROPE BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 EUROPE BIOPHARMACEUTICAL MARKET ANALYSIS- BY PRODUCT TYPE
9.3 EUROPE BIOPHARMACEUTICAL MARKET ANALYSIS- BY THERAPEUTIC AREAS
9.4 EUROPE BIOPHARMACEUTICAL MARKET ANALYSIS- BY END- USER
9.5 U.K.
9.6 FRANCE
9.7 GERMANY
9.8 ITALY
9.9 SPAIN
9.10 REST OF EUROPE

10 ASIA PACIFIC BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 ASIA PACIFIC BIOPHARMACEUTICAL MARKET ANALYSIS- BY PRODUCT TYPE
10.3 ASIA PACIFIC BIOPHARMACEUTICAL MARKET ANALYSIS- BY THERAPEUTIC AREAS
10.4 ASIA PACIFIC BIOPHARMACEUTICAL MARKET ANALYSIS- BY END- USER
10.5 INDIA
10.6 CHINA
10.7 JAPAN
10.8 REST OF ASIA PACIFIC

11 MIDDLE EAST AND AFRICA (MEA) BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 MEA BIOPHARMACEUTICAL MARKET ANALYSIS- BY PRODUCT TYPE
11.3 MEA BIOPHARMACEUTICAL MARKET ANALYSIS- BY THERAPEUTIC AREAS
11.4 MEA BIOPHARMACEUTICAL MARKET ANALYSIS- BY END- USER
11.5 SOUTH AFRICA
11.6 REST OF MIDDLE EAST AND AFRICA

12 LATIN AMERICA BIOPHARMACEUTICAL MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 LATIN AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY PRODUCT TYPE
12.3 LATIN AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY THERAPEUTIC AREAS
12.4 LATIN AMERICA BIOPHARMACEUTICAL MARKET ANALYSIS- BY END- USER
12.5 BRAZIL
12.6 REST OF LATIN AMERICA

13 COMPETATIVE LANDSCAPE
13.1 GLOBAL BIOPHARMACEUTICAL MARKET-COMPANY MARKET SHARE ANALYSIS

14 COMPANY PROFILES: (REVENUE,  PRODUCT TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
14.1 ABBVIE
14.2 AMGENINC
14.3 BRISTOL- MYERS SQUIBB
14.4 LG LIFE SCIENCE
14.5 PFIZER
14.6 JOHNSON& JOHNSON
14.7 ROCHE HOLDING AG
14.8 BIOCON LTD
14.9 RANBAXY LABORATORIES LTD
14.10 GLAXOSMITHKLINE